|
|
Glaxo SmithKline is the world's leading research based pharmaceuticals company. It was formed on December 27, 2000 as a result of merger of two leading international organizations viz., GlaxoWellcome and Smithkline Beecham.
The company is working hard to improve the quality of the human life by enabling people to do more, feel better and live longer. It believes that there is no achievement without integrity. The company has its headquarters in UK with operations based in USA, and has 85 manufacturing sites in over 37 countries. The company has combined sales of over 20 billion pounds, market share of about 7%, and intellectual property of more than 100,000 employees worldwide.
|
|
Out of these 100,000 employees, approximately 35% are in manufacturing units, 16% are in R&D, and 40% are in sales and marketing. The manufacturing plants of the company in India are located in Nabha, Rajahmundry and Sonepat, and have employee strength of about 2700.
GSK Consumer healthcare Ltd. and GSK Pharmaceuticals Ltd. are the two businesses of GSK in India with headquarters at Gurgaon, Haryana. Its products include:
1. GI & Analgesics: Crocin, and Eno
2. Rubefacients: Iodex
3. Nutritional: Boost, Horlicks, Viva, and Maltova
Contact Address:
GlaxoSmithKline Consumer Healthcare,
DLF Plaza Tower,
DLF Phase I, Gurgaon - 122002
Haryana, India.
Ph: 0124-2540700/ 5057700
Fax: 0124-2540720/2540721
e-mail: contact.4.qsk@qsk.com
Quarterly Results of Glaxo
Quarterly Results (Rs. in Millions) |
|
Dec 2006 (3rd quarter) |
Sept 2006
(2nd quarter) |
Dec 2005 (3rd quarter) |
|
Sales Turnover |
3488.9 |
4327.9 |
3430.5 |
Other Income |
299.4 |
253.6 |
209.7 |
Total Income |
3788.3 |
4581.5 |
3640.2 |
Total Expenditure |
2674.9 |
3045.2 |
2767.9 |
Operating Profit |
1113.4 |
1536.3 |
872.3 |
Interest |
0 |
0 |
0 |
Gross Profit |
1113.4 |
1536.3 |
872.3 |
Depreciation |
41.1 |
40.7 |
44.1 |
Tax |
390.7 |
504.9 |
315.8 |
Reported PAT |
677.9 |
2854.3 |
423.8 |
*Source: economictimes.indiatimes.com
Quarterly Results (in %) |
|
% Change
(Over Sep 2006) |
% Change (Over Dec 2005) |
|
Sales Turnover |
-19.39 |
1.7 |
Other Income |
18.06 |
42.78 |
Total Income |
-17.31 |
4.07 |
Total Expenditure |
-12.16 |
-3.36 |
Operating Profit |
-27.53 |
27.64 |
Interest |
0 |
0 |
Gross Profit |
-27.53 |
27.64 |
Depreciation |
0.98 |
-6.8 |
Tax |
|
|
Reported PAT |
-76.25 |
59.96 |
*Source: economictimes.indiatimes.com
Annual Results of Glaxo
Annual Unaudited Results (Rs. in Millions) |
|
(12 Months) |
(12 Months) |
% Changes |
Sales Turnover |
16,775.70 |
15,758.90 |
6.45 |
Other Income |
958.4 |
656.4 |
46.01 |
Total Income |
17,734.10 |
16,415.30 |
8.03 |
Total Expenditure |
12,016.10 |
11,478.90 |
4.68 |
Operating Profit |
5,718.00 |
4,936.40 |
15.83 |
Interest |
0 |
0 |
|
Gross Profit |
5,718.00 |
4,936.40 |
15.83 |
Depreciation |
158.5 |
157.3 |
0.76 |
Tax |
1,942.30 |
1,716.30 |
13.17 |
Reported PAT |
5,455.10 |
5,020.80 |
8.65 |
*Source: economictimes.indiatimes.com
|
